Coxsackievirus replication and the cell cycle: A potential regulatory mechanism for viral persistence/latency

Medical Microbiology and Immunology

Volumn 193, Issue 2-3, 2004, Pages 83-90

  Feuer, Ralph ^a   Mena, Ignacio ^a   Pagarigan, Robb R ^a   Hassett, Daniel E ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycle; Coxsackievirus; Persistence latency; Replication regulation

Indexed keywords

VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL; CELL CYCLE; CONTROLLED STUDY; COXSACKIE VIRUS; HUMAN; HUMAN CELL; LATENT PERIOD; MOUSE; NEWBORN; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA ANALYSIS; VIRUS REPLICATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL CYCLE; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; MICE; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 2542582265     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-003-0192-z     Document Type: Article

References (47)

1. Archard LC, Khan MA, Soteriou BA, Zhang H, Why HJ, Robinson NM, Richardson PJ (1998) Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum Pathol 29:578-584
2. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757
3. Billeter MA, Cattaneo R, Spielhofer P, Kaelin K, Huber M, Schmid A, Baczko K, Meulin V ter (1994) Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 724:367-377
4. Brodsky VY, Sarkisov DS, Arefyeva AM, Panova NW (1993) DNA and protein relations in cardiomyocytes. Growth reserve in cardiac muscle. Eur J Histochem 37:199-206
5. Couderc T, Girard S, Pelletier I, Gosselin AS, Destombes J, Thiesson D, Colbere-Garapin F, Blondel B (2001) Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system. Dev Biol (Basel) 105:225-230
6. Dalakas MC (1986) New neuromuscular symptoms in patients with old poliomyelitis: a three- year follow-up study. Eur Neurol 25:381-387
7. Dalakas MC (1987) New neuromuscular symptoms after old polio ("the post-polio syndrome"): clinical studies and pathogenetic mechanisms. Birth Defects Orig Artic Ser 23:241-264
8. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J (1986) A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314:959-963
9. De la Fuente G, Palacios O, Villagra E, Villanueva ME (1995) Isolation of Coxsackieviruses B5 in a fatal case of meningoencephalitis. Rev Med Chil 123:1510-1513
10. Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B (1997) Persistent poliovirus infection in mouse motoneurons. J Virol 71:1621-1628
11. Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231-237
12. Estes ML, Rorke LB (1986) Liquefactive necrosis in Coxsackie B encephalitis. Arch Pathol Lab Med 110:1090-1092
13. Feuer R, Mena I, Pagarigan RR, Slifka MK, Whitton JL (2002) Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76:4430-4440
14. Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, Shimizu A (2000) Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36:1920-1926
15. Gage FH (2000) Mammalian neural stem cells. Science 287:1433-1438
16. Gascon GG (1996) Subacute sclerosing panencephalitis. Semin Pediatr Neurol 3:260-269
17. Gauntt CJ, Jones DC, Huntington HW, Arizpe HM, Gudvangen RJ, DeShambo RM (1984) Murine forebrain anomalies induced by coxsackievirus B3 variants. J Med Virol 14:341-355
18. Girard S, Gosselin AS, Pelletier I, Colbere-Garapin F, Couderc T, Blondel B (2002) Restriction of poliovirus RNA replication in persistently infected nerve cells. J Gen Virol 83:1087-1093
19. Hassett DE, Zhang J, Slifka MK, Whitton JL (2000) Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J Virol 74:2620-2627
20. + T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720-6728
21. Huber M, Watson KA, Selinka HC, Carthy CM, Klingel K, McManus BM, Kandolf R (1999) Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587-3594
22. Huber SA, Haisch C, Lodge PA (1990) Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J Virol 64:4516-4522
23. Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, Aymard M, Kopecka H (1999) Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 246:472-476
24. Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019-1032
25. Kim KS, Hufnagel G, Chapman NM, Tracy S (2001) The group B coxsackieviruses and myocarditis. Rev Med Virol 11:355-368
26. Klingel K, Rieger P, Mall G, Selinka HC, Huber M, Kandolf R (1998) Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest 78:1227-1237
27. Li Y, Peng T, Yang Y, Niu C, Archard LC, Zhang H (2000) High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83:696-701
28. Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM (2000) The tyrosine kinase p561ck is essential in coxsackievirus B3-mediated heart disease. Nat Med 6:429-434
29. Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, Carthy C, Wilson JE, Yang D, McManus BM (2002) Coxsackievirus B3 replication Is reduced by inhibition of the extracellular signal-regulated Kinase (ERK) signaling pathway. J Virol 76:3365-3373
30. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard JR, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205-1215
31. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL (2000) Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276-288
32. Modlin JF, Rotbart HA (1997) Group B coxsackie disease in children. Curr Top Microbiol Immunol 223:53-80
33. Norrby E, Kristensson K (1997) Measles virus in the brain. Brain Res Bull 44:213-220
34. Norris CM, Danis PG, Gardner TD (1999) Aseptic meningitis in the newborn and young infant. Am Fam Physician 59:2761-2770
35. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561-1569
36. Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU (2000) A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev 14:2028-2045
37. Pyronnet S, Pradayrol L, Sonenberg N (2000) A cell cycle-dependent internal ribosome entry site. Mol Cell 5:607-616
38. Ramirez JC, Fairen A, Almendral JM (1996) Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol 70:8109-8116
39. Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P (2000) Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol 81:2755-2762
40. Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113-10121
41. Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1991) Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654-6660
42. Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1994) Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med 123:346-356
43. Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673-686
44. Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU (1998) Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450-457
45. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan LW, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444-1453
46. Wynford-Thomas D, Williams ED (1986) Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 19:179-182
47. + T cell responses to DNA vaccines. J Virol 76:11911-11919